SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
--------
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): November 8, 2002
-----------------
Celsion Corporation
--------------------
(Exact Name of Registrant as Specified in Charter)
Delaware 000-14242 52-1256615
- ---------------------------- ------------- ----------------------
(State or Other Jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification No.)
10220-I Old Columbia Road, Columbia, Maryland 21046-1705
- -------------------------------------------------------------------------------
(Address of principal executive office) (Zip Code)
Registrant's telephone number, including area code: (410) 290-5390
--------------
- --------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
Item 5. Other Events
On November 11, the Company issued a press release reporting that, at a Special
Meeting held on November 8, 2002, its stockholders approved an amendment to the
Company's charter increasing the number of authorized shares of common stock
from 150 million to 200 million. A copy of the press release is attached as
Exhibit 99.1 to this Report on Form 8-K.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
CELSION CORPORATION
Date: November 11, 2002 By: /s/ Anthony P. Deasey
---------------------------------------
Anthony P. Deasey
Executive Vice President - Finance
and Administration and
Chief Financial Officer
3
EXHIBIT INDEX
-------------
Exhibit Description
99.1 Press Release dated November 11, 2002.
4
Celsion Corporation
10220-I Old Columbia Road, Columbia MD 21046-1705
T 410.290-5390 F 410.290.5394
For Further Information Contact:
Tony Deasey Ira Weingarten/Steve Chizzik Frank Benadetto
Celsion Corporation Equity Communications Mirador Consulting
410.290.5390 888.530.7051 877.647.2367 (Mirador)
tony@celsion.com equity@Silcom.com fb@miradorconsulting.com
------------------------
CELSION SHAREHOLDERS APPROVE INCREASE IN COMMON SHARE AUTHORIZATION
Columbia, MD - November 11, 2002: CELSION CORPORATION (AMEX:CLN) today announced
that at a Special Meeting held on Friday, November 8, 2002, its stockholders
approved a charter amendment increasing the number of its authorized shares of
common stock from 150 to 200 million.
About Celsion: Celsion Corporation, based in Columbia, Maryland, is a research
and development company dedicated to commercializing medical treatment systems
for cancer and other diseases using focused-heat technology delivered by
patented microwave technology. Celsion has research, license or
commercialization agreements with leading institutions such as Duke University
Medical Center, Massachusetts Institute of Technology, Harbor UCLA Medical
Center, the Center for Breast Surgery at Columbia Hospital in Florida,
Montefiore Medical Center, Memorial Sloan Kettering Cancer Center in New York,
Roswell Park Cancer Institute in Buffalo, New York, and Duke University. For
more information on Celsion, visit our website: http//www.celsion.com.
Forward-looking statements in this release are made pursuant to the "safe
harbor" provisions of the Private Securities Litigation Reform Act of 1995.
Investors are cautioned that such forward-looking statements involve risks and
uncertainties including, without limitation, unforeseen changes in the course of
research and development activities and in clinical trials; possible changes in
cost and timing of development and testing, capital structure, and other
financial items; changes in approaches to medical treatment; introduction of new
products by others; possible acquisitions of other technologies, assets or
businesses; possible actions by customers, suppliers, competitors, regulatory
authorities; and other risks detailed from time to time in the Company's
periodic reports filed with the Securities and Exchange Commission.
# # #